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ll-I et 111 .tJlohlOOCS anrubit bacterial grO\ th by in3cDv ong
pem l1Jm~bmdmg protems (PBPs). wluch arc located on the
outennost tJ e o( the cywphmlJc membrane r1J. Affilury for
PBP~ I~ an IlllPOtt.lnt f.,ccor that dctcflllIne. the bactericidal or
ha tenO~t:ICl pr pernc.~ of these Irug!> and their ultimate
effectiveness on the ba terial cc1J~ [2J.
The serum protem bmdmg o( a number of cephalosporin
has raised a number o( que~cions ahout the antimicrobial
CffCCtlVCI1CSS of cllesc agcnts. ne of t.be c que tions IS
whet11er anciblooc molecull'5 bound to plasrn;J protem arc
hkel t eros me outc:r m('mbr:lIlc of Gr:lIl.1-nc:gaovc
b cteria. The addlOon o(serum albumin in virr docs indeed
dinunish me eflcctivenc s of antimicrobi Is thM bind
extensively to thiS protein.
eftnaxone IS. parenteral cephalosporin that displays a
hr ad spectrum of ctlviry against both Gram-neg, tlve and
ram-pomlve organISms and. like ther p-IaCtallls.
mhibi bacten I growtll by In. ctivating PBPs. It ditTers
from the ther Illcmbc thi cla in having a I ng ertlm
hal -hfe. which aUow once-dajly dosing. While helping to
lengthen dosing II1tcrva.ls. the CX[Cn5IVC serum protein
binding of cefrn xone obvl u Iy raises the quesnon 0 Its
re 1 anciml roblal eni: tiveness in viv . H \ ever. high
protein binding cannot imp. ir the in vivo activity of
c:ftri. xone If lhe (ree drug fraction in pl. ilia
extra ascular fluids is higher than that required to in~hibil
essential PDP [31.
We compared the PDP bmding 0 ceftnaxone and
ceforaxmle ( cephalosponn With low hUl1l:lI1 Ibuuun
banding) in the presence of hunun enun albumin (I-ISA) • r
con enrranoflS c mparable \vith plasm levcls.
Esr/ltrirJrilJ Cllli K 12 was gr wn in haken cuJcures of I L
Mueller-Hint n broth 111 L COlli al flasks at 37° . When
culture tcached the cxponenti.1 growth phase (0.8
turbldlry at D 600). they were divided into aliquo of
200 mL and H A was added (40 mg/mL. final conccnrra-
oon). After 5 min. antibiotic at different concentration
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werc ,dded and in lib. Clon was contll1ued for 15 min at
37~C With moderate shaking.. amples were then ch.iUed
rapidly In ICC, centrifuged at 25 OOll g (or 5 min at 2 C. and
washed twi e with 10 mL 0 Icc-cold 50 11m sodium
pho\phatc buffcr (pH 7). A(ter su~pension 111 5 mL of ice-
old butTer. the b:lcteria were broken by sonic, ti n (or five
15-s period \ ith cooling on ice. ell enveloJ cs \ f're
\ ashed twice In icc-cooled buffer by centrifugation at
LOU 000 g (or 30 rnjn at 2° and the pellct was resuspended
In 200 j.lL of Ice-cold buffer. R dl active pelllcillin (10 j.lg/
IlIL) \ as added 10 thl.' i ola.ted envelopes to saturate PDPs
th. t had nor previou Iy bound unlabelled ~-lactams
penctr. Ling into the living ba teri•. The labeUed pBPs
were solubilized by :lrkosyl; PDPs were eparnted by SO -
PAG ,nd detected on gels by Ouorography [l).
The MJ S 0 boch ccfrnaxone and ccfmaximc (or E. coli
KI2 were 0.125 ~lg/mL. [n the pre ence of 4% H A. the
MI cefrriaxone ro e to 1 j.lg/m while that ofcefotax.ime
was un h. nged.
When growing E. coli cell were jn ul>ated with 0.1. I
and I 0 ~lg/m.L 0 ce(triaxone in the presen e or abs nee of
1-1 A; HSA dId not IllIpair the ability of the antll>i ric to
aturatc PBP 2. od 3 and to bind PDP I extensIvely at 10
~lg/mL. but reduced the bindll1g o( 1 j.lg/l11L c<:(tri:lxonc to
aLI es. euti.1 pBPs by 72%- 0% and completely inhibited
the binding 0(0.1 J.1g/mL certri xone. It should be borne in
ound dut celiriaxone concentrations 24 h after adminis-
traClon re 13.2 ± 3.2 mg/L Jfter I g Lv. Jnd 12.6 j.lg/mL
after I g Lm.
The PHp l>indlllg f both drugs in cdl growing III the
presence (H'A wa Ihen c mparcd t drug con ent .-
tion thac re found in pia m3 after a 1-g illtra\'enous
infu iOIl. According to published d c., the pl. sm con-
centratioll of e(tri, xonc decrease (rom mean Icvels o(
IllJ.9 ± I .1 j.lg/mL to me:ln value of 46 ± .1 J.lg/mL in
8 h. nd the plasma concentrations o( cefmaxime drop
from 20 ± 1. J.lg/mL to ~ 0.\ j.lg/mL ill the same
interval. The lowe t concentration of certriaxone used
(i.e. that found 8 h after admiltistration) sarur:lted both
PBP 2 • nd 3 and b und 90% of PDP I; this concentration
caused filament fonnarion and rapid lysis :lfter 2 h
Illcubatl n. III contr:lSt, concentr c:ions o( cefot:lxlmc
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fOllnd -1 h ,Iftel' ad1ll1111'traliOIl ',llllr.1ted "III\, P13P J ,lIId
,',llbe,1 tiblll"llt ti'1'I11.1111111 .111.1 ,low Iy"',
At Cl1ll,','lllr,lllom IlI.lUHJIIlCd 111 thl' 1'1.1~lll.1 I'll' H h,
'lIJ1inelll cc·llT1.I ... OlIl' r,'lll.IUll'd 1I11l>Ollll,J to 'ISA to ud1lblt
l>,IL'll'l'l,11 growth, 1Il,IClI\'arc 1\\'0 of three e,,,'un,11 Pili>, III
1:, ",/" .Iud Illdu " IlIorl'hologlral ,dtl'l'aU(lIh ,111.1 cdl Iy,i,
Th .ugh llUll>' c"l'h,II"'l'onlh ,h,\\\ I'rIIll:ll) ,.,tillil)' li,r 1'131' .1
,111.1 hlllJ onl\' Pill> J at rhl'lr lo\\""t l'll'cCtl\'" com:L'ntl',llI"1I'
HI, rhe ~.111I1'.1I"1Il of hoth 1'131' .2 al1d ,\ I'C,ult, 1II lIlorl' rapId
Iy'" ,lIlel .111 ellh,llllcd h,c[ellcld,ll clrcct 12,:;1,
Thlh. the lugh ,enUll pror"l1l hUldlllg ,Ioe< lIut 1I111'Jtr rhl'
"hlhr)' of ,din,l)wll" to 1111111>11 L'''I'IHI.II I'llI', ,md (, 11"'-
11I"Illly lhl' high III \'1\'" "f i',ll'y of the' drug,
I'llI', of ,111 1:/1"""/"" 1""111«(','" ha"l' "Illlbr I'hy,wlogH:.d
prop"fll'" ,1I1l1 ~-I.ICt;1I11 atlilllrv; thll>, rill" l'Oll1l"ll'.lhk
c/)i,'a..:lL" ,ho\\'n b\' 'l't'rn,IXOlle alld refotaxlllle 1II III 1:<'-
1I011 c,lll\ed hy lh,"" organlSlll' probahly :In", .1~ III the
C,I l' of E (,.Ii, 1'1'0111 Ihe 1:1<:t lhat free (efcn.l.... olw
cnncemr,HIllI" .11',' 1Il,llI1tJil1"d IiII' 'e\'er:!1 hOllr, .11""",
the' /vll<.' ,1Jld rhe IlIlnlllllllll COl1centr.lrion, I'Clllllred I.ll
",tlll'.lte n\l'I1lI,d PilI'" Ph,ll'llI,I,'okllll'lIL' '1II,h" 11.1\'"
IlI,ked <howll lhar rhL' ~"nlill COllcelHr,trIOlh of cdtnaxon,'
Fontana et al Affinities 01 cephalosporins lor PBPs ~l
2-1 h .lrler ~dmllmll'arlOn far exceed both che M IC:s ,lI1d lhe
M13C, o( mallY /;""'1"1",,1/'/<'1'111(1',1<', IIlCllldlllg [3-la t.lllla>c-
produ('lllg 'crall1',
REFERENCES
I. "~'I'.ln IH:. l)l ..tlmt Pl'Uhl1lul hllUhll~ rmh.'llh 1I1\'I,ht."\i III Ilh.' ,11\'1'\1'111.
dml~tlhJII ,lIul ,h,lI'C ,.1 I:.~dj""rltld o'li KI.1 IJr., 'V,M At'jlll ,~, (rS~1 11)7;;.
7~ 1l lt "J-.\llOJ
'.Llt.' C. (unl.l~lu C. ,M:lI1Jth)1 A. (;,t1UII C. V..hv;nJ. \, h'lU.UIJ R
1.1l).t,-'IJo {or bJt.'h:nmUtlC Jod ha,:n:nndJl.h:nvu,,:'\ tJ,'hc.. u-1Jll.l.1U .111lllJIOIIl,\
.lg.\lIhr I: 1,,'nt/.lI' +l-" t h.ft: 111 ~htTC'n:-nf P't'JUnJlin-blllchnl! prutcil \,
.~I"'rHlhht/1 A~'(''';J (.'/II'HII""I"' 1'.4):;, 39 ~L!-H
M I :UH.tl.1 PJ. I (tHo'h V. \''lhte,-'k,,'' K "rnlL'1Il bmJIl1~ "If u"linJx()m' lU
c'·,\;:O,;\\,.i\l'ul.lr Ihm".) P/IIl"" Sa l'nUI, 77 ~Ilt-...
( lin), NAC. On I). llu..~ G'\ ,U.....uhon IG. Compo..··uuoll Ufl)('tl-I.hl.,m
.IUllbll'l1('+' for Illl' pt.'llln\tIJ,·b,ndlnJ: prUl(:UI\ f 1).,1·lld(lmN'~' ..rN~~r'hh..l,
I:Il't'n./Plral" ,/lSo".w. KldJ~jrU,1 .lfn':\.tl'It 1. l'nlltlrt ,,1l\,V"I1, JIHI /: ,."nth", .•'0/,
CUlllp.UI\Oll \\1111 .uHlhJ\~h,·n.\1 JlU\'lf\' JIIJ C"11"c:-Ll\ Upt'''' h.lc(cnJIIHUrphfll-
\"'~ ,·IHtuura.,I• .-I.~I'It'i C'lfllrll,I'IT 1l1itJ. 16 J~:l
<':lItllI.lUII 1, IIh,t'm \. BIItHr·Klt'lIt ll. 1\\,,11 JF. \ri-lld E, W,lh;\IWMII R
Illvoln:lllcllt t.)(pC.f1Kllhll~bllldJlI~pr11h,"11J 1. \\llh mh1.:r ~X"III~II1I1I-bllh_hn!-t
plflt(',"' m 1),,1\ ul" ':iiI/rill/lilt II,]' 11'~ II.UIl1(' l'k"o-IJ':lJrH ,UlIII)ll..·)(J~" JJdl1 .and
III ,\,,\'llcf!V,nc I~·t'll dTl....~r 01 JluJmOl'11bu (JU('CI.IIUJJJlll ~-i,pwlflfnl'l .~.I! w\
(:Irnml"wr I IJ 6; JU 1)llh_ I ~"
, 2000 Copyrlghl bv lhe European SOCIOIV 01 Clinical MicrobIology and Int6CltOuS D,seases eMI, & (Suppl J' 82-83
